Phase II randomised trial of pracinostat in combination with standard-of-care in at least one haematological malignancy.
Latest Information Update: 21 Nov 2012
At a glance
- Drugs Pracinostat (Primary)
- Indications Haematological malignancies
- Focus Therapeutic Use
- Sponsors MEI Pharma
- 21 Nov 2012 New trial record